🟢 Lantern Pharma is trading 14.51% up today in pre-market with catalyst still unconfirmed

Lantern Pharma is trading 14.51% up at $2.21 in pre-market, with the catalyst unconfirmed.

• The stock rose 13.53% to $1.93 on September 16.
• No company-specific announcement dated September 16 or September 17, 2026, appears on its news page; the latest listed update is from June 2.
• The broader market is firmer pre-market, but that moderate improvement does not clearly explain Lantern Pharma’s larger move; continue monitoring for delayed biotech or company news.